STIM1 and colon adenocarcinoma: Moreover, we collected all available COAD patients without considering the STIM1 expression value to carry out a prognostic predictor-based survival analysis, and results revealed a decline in the ROC performance (AUROC = 65.8%, Supplementary Figure S6B).